 | Up a level |
Halbach, M., Abraham, W. T., Butter, C., Ducharme, A., Klug, D., Little, W. C., Lovett, E., Schafer, J. E., Senni, E., Swarup, V., Wachter, R., Weaver, F. A., Zile, M. R. and Muller-Ehmsen, J. (2016). Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. Eur. Heart J., 37. S. 724 - 726. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Halbach, M., Hickethier, T., Madershahian, N., Brandt, M. C., Hoppe, U. C., Velden, R., Lovett, E. and Muller-Ehmsen, J. (2014). Baroreflex activation therapy in resistant hypertension - acute on/off effects and chronic blood pressure reduction. Eur. Heart J., 35. S. 744 - 746. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Krausgrill, B., Sahito, R. G., Sheng, X., Maass, M., Urban, K., Brockmeier, K., Muller-Ehmsen, J., Hescheler, J. and Pfannkuche, K. (2014). Optimal dose of mesenchymal bone-marrow cells added to in-vitro grown mixed clusters improves persistence of murine embryonic stem cell derived cardiomyocytes after intramyocardial transplantation. Eur. Heart J., 35. S. 110 - 112. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645